Literature DB >> 1915525

High dose intravenous gamma-globulin in intractable epilepsy of childhood.

A Etzioni1, M Jaffe, S Pollack, N Zelnik, A Benderly, Y Tal.   

Abstract

Eight children aged between 1.3 and 13 years suffering from epilepsy refractory to conventional anticonvulsive therapy were treated with high dose intravenous gamma globulin (200 mg/kg, 3 times per week, repeated after 3 weeks). Immunological studies after therapy showed normal results. In four children, clinical and EEG findings markedly improved. In one other case a partial response was noted. No improvement was observed in the remaining three cases. We confirm that although the mechanism is still obscure, high doses of i.v. gammaglobulin may have a beneficial effect in a significant number of children with intractable epilepsy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915525     DOI: 10.1007/bf02072634

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Effects of gamma-globulin therapy in severely epileptic children.

Authors:  R Bedini; M R de Feo; A Orano; L Rocchi
Journal:  Epilepsia       Date:  1985 Jan-Feb       Impact factor: 5.864

2.  IgG2 deficiency and intractable epilepsy of childhood.

Authors:  M Duse; S Tiberti; A Plebani; M A Avanzini; M Gardenghi; E Menegati; V Monafo; A G Ugazio
Journal:  Monogr Allergy       Date:  1986

3.  Gamma globulin for antibody-mediated pure red-cell aplasia.

Authors:  A Etzioni; S Pollack; A Benderly
Journal:  N Engl J Med       Date:  1988-04-14       Impact factor: 91.245

4.  Intravenous gammaglobulin for post-encephalitic epilepsy.

Authors:  P Sandstedt; V Kostulas; L E Larsson
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

5.  High dose gammaglobulin for intractable childhood epilepsy.

Authors:  M Ariizumi; K Baba; H Shiihara; K Ogawa; S Hibio; Y Suzuki; S Ryo; T Momoki
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

6.  [The effects of gammaglobulins in resistant epilepsies. A preliminary study (author's transl)].

Authors:  F Laffont; S Esnault; A Gilbert; M A Peytour; H P Cathala; J P Eygonnet
Journal:  Ann Med Interne (Paris)       Date:  1979

7.  Defective humoral and cellular immune functions associated with veno-occlusive disease of the liver.

Authors:  A Etzioni; A Benderly; E Rosenthal; V Shehadah; L Auslander; N Lahat; S Pollack
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

8.  [The treatment of epileptic encephalopathies with gamma globulin in children (author's transl)].

Authors:  J C Péchadre; B Sauvezie; C Osier; J Gibert
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1977 Oct-Dec

9.  Use of intravenous immune globulin in the treatment of seizure disorders.

Authors:  S A Schwartz; K E Gordon; M V Johnston; G W Goldstein
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

Review 10.  High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses.

Authors:  A Etzioni; S Pollack
Journal:  Autoimmunity       Date:  1989       Impact factor: 2.815

  10 in total
  1 in total

1.  High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study.

Authors:  B G van Engelen; W O Renier; C M Weemaes; P F Strengers; P J Bernsen; S L Notermans
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.